AFL vs IBIO · P/E 14, rev $4.12B vs rev $100.0K
Aflac Incorporated (AFL) versus iBio, Inc. Common Stock (IBIO) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported AFL revenue for 2026-06-30 was $4.12B. Net income was $825.0M. Revenue was down 5.3% from 2026-03-31 to 2026-06-30. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. IBIO currently screens at market cap $13.4M.
Not investment advice. Open the AFL and IBIO stock pages for the full models.
Not investment advice.